OTC Healthcare in the US to 2011

Introduction

This databook is a detailed information resource covering all the key data points on OTC Healthcare in the US. It includes comprehensive value volume segmentation and market share data. The databook supplies actual data to 2006 and full forecasts to 2011.

Scope

• Contains information on:Analgesics,Cough & cold,Indigestion,Medicated skin products,Traditional medicines,Vitamins & Other OTC healthcare products
• Provides market value, volume, expenditure and consumption data by market, segment and subsegment
• Includes company and brand share data by categories

Highlights

The market for OTC Healthcare in the US increased between 2001-2006, growing at an average annual rate of 3.1%.
The leading company in the market in 2006 was Pfizer Inc. The second-largest player was Wyeth with GlaxoSmithKline Plc in third place.

Reasons to Purchase

• Discover the major quantitative trends affecting the OTC Healthcare markets
• Understand consumers' consumption and expenditure patterns
• Understand the future direction of the market with reliable historical data and full five year forecasting

• Chapter 1 EXECUTIVE SUMMARY
  • Summary Market Level - OTC Healthcare
  • Summary category level - Analgesics
  • Summary category level - Cough and Cold Preparations
  • Summary category level - Traditional Medicines
  • Summary category level - First Aid Kits
  • Summary category level - Indigestion Preparations
  • Summary category level - Vitamins and Minerals
  • Summary category level - Plasters & Bandages
  • Summary category level - Medicated Skin Products
  • Summary category level - Other OTC Healthcare Products
  • Summary category level - Topical OTC Medicines
• Chapter 2 INTRODUCTION
  • What is this report about?
  • How to use this report
  • Market Definition
• Chapter 3 MARKET OVERVIEW
  • Value Analysis, 2001-2006
  • Value Analysis, 2006-2011
  • Company and Brand Share Analysis
  • Expenditure & consumption per capita
• Chapter 4 LEADING COMPANY PROFILES
  • Pfizer Inc
  • Wyeth
• Chapter 5 CATEGORY ANALYSIS - ANALGESICS
  • Value Analysis, 2001-2006
  • Value Analysis, 2006-2011
  • Company and Brand Share Analysis
  • Expenditure & consumption per capita
• Chapter 6 CATEGORY ANALYSIS - COUGH AND COLD PREPARATIONS
  • Value Analysis, 2001-2006
  • Value Analysis, 2006-2011
  • Company and Brand Share Analysis
  • Expenditure & consumption per capita
• Chapter 7 CATEGORY ANALYSIS - TRADITIONAL MEDICINES
  • Value Analysis, 2001-2006
  • Value Analysis, 2006-2011
  • Company and Brand Share Analysis
  • Expenditure & consumption per capita
• Chapter 8 CATEGORY ANALYSIS - FIRST AID KITS
  • Value Analysis, 2001-2006
  • Value Analysis, 2006-2011
  • Company and Brand Share Analysis
  • Expenditure & consumption per capita
• Chapter 9 CATEGORY ANALYSIS - INDIGESTION PREPARATIONS
  • Value Analysis, 2001-2006
  • Value Analysis, 2006-2011
  • Company and Brand Share Analysis
  • Expenditure & consumption per capita
• Chapter 10 CATEGORY ANALYSIS - VITAMINS AND MINERALS
  • Value Analysis, 2001-2006
  • Value Analysis, 2006-2011
  • Company and Brand Share Analysis
  • Expenditure & consumption per capita
• Chapter 11 CATEGORY ANALYSIS - PLASTERS & BANDAGES
  • Value Analysis, 2001-2006
  • Value Analysis, 2006-2011
  • Company and Brand Share Analysis
  • Expenditure & consumption per capita
• Chapter 12 CATEGORY ANALYSIS - MEDICATED SKIN PRODUCTS
  • Value Analysis, 2001-2006
  • Value Analysis, 2006-2011
  • Company and Brand Share Analysis
  • Expenditure & consumption per capita
• Chapter 13 CATEGORY ANALYSIS - OTHER OTC HEALTHCARE PRODUCTS
  • Value Analysis, 2001-2006
  • Value Analysis, 2006-2011
  • Company and Brand Share Analysis
  • Expenditure & consumption per capita
• Chapter 14 CATEGORY ANALYSIS - TOPICAL OTC MEDICINES
  • Value Analysis, 2001-2006
  • Value Analysis, 2006-2011
  • Company and Brand Share Analysis
  • Expenditure & consumption per capita
• Chapter 15 COUNTRY COMPARISON
  • Value
  • Market Share
• Chapter 16 NEW PRODUCT DEVELOPMENT
  • Product launches over time
  • Recent product launches
• Chapter 17 US SOCIOECONOMIC PROFILE
  • Country Overview
  • Key Facts
  • Political Overview
  • US Economic Overview
• Chapter 18 US MACROECONOMIC PROFILE
  • Macroeconomic Indicators
• Chapter 19 RESEARCH METHODOLOGY
  • Methodology overview
  • Secondary research
  • Market modelling
  • Primary research
  • Data finalisation
  • Ongoing research
• Chapter 20 APPENDIX
  • Future readings
  • How to contact experts in your industry
• LIST OF FIGURES
  • Figure1: US OTC Healthcare value & value forecast, 2001-2011 (USD m, nominal prices)
  • Figure2: US OTC Healthcare category growth comparison, by value, 2001-2011
  • Figure3: US OTC Healthcare company share, by value, 2005-2006 (%)
  • Figure4: US Analgesics value & value forecast, 2001-2011 (USD m, nominal prices)
  • Figure5: US Analgesics category growth comparison, by value, 2001-2011
  • Figure6: US Analgesics company share, by value, 2005-2006 (%)
  • Figure7: US Cough and Cold Preparations value & value forecast, 2001-2011 (USD m, nominal prices)
  • Figure8: US Cough and Cold Preparations category growth comparison, by value, 2001-2011
  • Figure9: US Cough and Cold Preparations company share, by value, 2005-2006 (%)
  • Figure10: US Traditional Medicines value & value forecast, 2001-2011 (USD m, nominal prices)
  • Figure11: US First Aid Kits value & value forecast, 2001-2011 (USD m, nominal prices)
  • Figure12: US First Aid Kits company share, by value, 2005-2006 (%)
  • Figure13: US Indigestion Preparations value & value forecast, 2001-2011 (USD m, nominal prices)
  • Figure14: US Indigestion Preparations category growth comparison, by value, 2001-2011
  • Figure15: US Indigestion Preparations company share, by value, 2005-2006 (%)
  • Figure16: US Vitamins and Minerals value & value forecast, 2001-2011 (USD m, nominal prices)
  • Figure17: US Vitamins and Minerals category growth comparison, by value, 2001-2011
  • Figure18: US Vitamins and Minerals company share, by value, 2005-2006 (%)
  • Figure19: US Plasters & Bandages value & value forecast, 2001-2011 (USD m, nominal prices)
  • Figure20: US Plasters & Bandages category growth comparison, by value, 2001-2011
  • Figure21: US Plasters & Bandages company share, by value, 2005-2006 (%)
  • Figure22: US Medicated Skin Products value & value forecast, 2001-2011 (USD m, nominal prices)
  • Figure23: US Medicated Skin Products category growth comparison, by value, 2001-2011
  • Figure24: US Medicated Skin Products company share, by value, 2005-2006 (%)
  • Figure25: US Other OTC Healthcare Products value & value forecast, 2001-2011 (USD m, nominal prices)
  • Figure26: US Other OTC Healthcare Products category growth comparison, by value, 2001-2011
  • Figure27: US Other OTC Healthcare Products company share, by value, 2005-2006 (%)
  • Figure28: US Topical OTC Medicines value & value forecast, 2001-2011 (USD m, nominal prices)
  • Figure29: US Topical OTC Medicines category growth comparison, by value, 2001-2011
  • Figure30: Global OTC Healthcare market split (value terms, 2006) Top 5 countries
  • Figure31: Global OTC Healthcare market value, 2001 2006 (Top 5 countries)
  • Figure32: Map of the US
  • Figure33: Annual data review process
• LIST OF TABLES
  • Table 1: OTC Healthcare category definitions
  • Table 2: US OTC Healthcare value, 2001-2006 (USD m, nominal prices)
  • Table 3: US OTC Healthcare value forecast, 2006-2011 (USD m, nominal prices)
  • Table 4: US OTC Healthcare brand share, by value, 2005-2006 (%)
  • Table 5: US OTC Healthcare value, by brand 2005-2006 (USD m nominal prices)
  • Table 6: US OTC Healthcare company share by value, 2005-2006 (%)
  • Table 7: US OTC Healthcare value, by company, 2005-2006 (USD m nominal prices)
  • Table 8: US OTC Healthcare expenditure per capita, 2001-2006 (USD, nominal prices)
  • Table 9: US OTC Healthcare forecast expenditure per capita, 2006-2011 (USD, nominal prices)
  • Table 10: Pfizer Inc Key Facts
  • Table 11: Wyeth Key Facts
  • Table 12: US Analgesics value, 2001-2006 (USD m, nominal prices)
  • Table 13: US Analgesics value forecast, 2006-2011 (USD m, nominal prices)
  • Table 14: US Analgesics brand share, by value, 2005-2006 (%)
  • Table 15: US Analgesics value, by brand 2005-2006 (USD m nominal prices)
  • Table 16: US Analgesics company share by value, 2005-2006 (%)
  • Table 17: US Analgesics value, by company, 2005-2006 (USD m nominal prices)
  • Table 18: US Analgesics expenditure per capita, 2001-2006 (USD, nominal prices)
  • Table 19: US Analgesics forecast expenditure per capita, 2006-2011 (USD, nominal prices)
  • Table 20: US Cough and Cold Preparations value, 2001-2006 (USD m, nominal prices)
  • Table 21: US Cough and Cold Preparations value forecast, 2006-2011 (USD m, nominal prices)
  • Table 22: US Cough and Cold Preparations brand share, by value, 2005-2006 (%)
  • Table 23: US Cough and Cold Preparations value, by brand 2005-2006 (USD m nominal prices)
  • Table 24: US Cough and Cold Preparations company share by value, 2005-2006 (%)
  • Table 25: US Cough and Cold Preparations value, by company, 2005-2006 (USD m nominal prices)
  • Table 26: US Cough and Cold Preparations expenditure per capita, 2001-2006 (USD, nominal prices)
  • Table 27: US Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (USD, nominal prices)
  • Table 28: US Traditional Medicines value, 2001-2006 (USD m, nominal prices)
  • Table 29: US Traditional Medicines value forecast, 2006-2011 (USD m, nominal prices)
  • Table 30: US Traditional Medicines brand share, by value, 2005-2006 (%)
  • Table 31: US Traditional Medicines value, by brand 2005-2006 (USD m nominal prices)
  • Table 32: US Traditional Medicines company share by value, 2005-2006 (%)
  • Table 33: US Traditional Medicines value, by company, 2005-2006 (USD m nominal prices)
  • Table 34: US Traditional Medicines expenditure per capita, 2001-2006 (USD, nominal prices)
  • Table 35: US Traditional Medicines forecast expenditure per capita, 2006-2011 (USD, nominal prices)
  • Table 36: US First Aid Kits value, 2001-2006 (USD m, nominal prices)
  • Table 37: US First Aid Kits value forecast, 2006-2011 (USD m, nominal prices)
  • Table 38: US First Aid Kits brand share, by value, 2005-2006 (%)
  • Table 39: US First Aid Kits value, by brand 2005-2006 (USD m nominal prices)
  • Table 40: US First Aid Kits company share by value, 2005-2006 (%)
  • Table 41: US First Aid Kits value, by company, 2005-2006 (USD m nominal prices)
  • Table 42: US First Aid Kits expenditure per capita, 2001-2006 (USD, nominal prices)
  • Table 43: US First Aid Kits forecast expenditure per capita, 2006-2011 (USD, nominal prices)
  • Table 44: US Indigestion Preparations value, 2001-2006 (USD m, nominal prices)
  • Table 45: US Indigestion Preparations value forecast, 2006-2011 (USD m, nominal prices)
  • Table 46: US Indigestion Preparations brand share, by value, 2005-2006 (%)
  • Table 47: US Indigestion Preparations value, by brand 2005-2006 (USD m nominal prices)
  • Table 48: US Indigestion Preparations company share by value, 2005-2006 (%)
  • Table 49: US Indigestion Preparations value, by company, 2005-2006 (USD m nominal prices)
  • Table 50: US Indigestion Preparations expenditure per capita, 2001-2006 (USD nominal prices)
  • Table 51: US Indigestion Preparations forecast expenditure per capita, 2006-2011 (USD nominal prices)
  • Table 52: US Vitamins and Minerals value, 2001-2006 (USD m, nominal prices)
  • Table 53: US Vitamins and Minerals value forecast, 2006-2011 (USD m, nominal prices)
  • Table 54: US Vitamins and Minerals brand share, by value, 2005-2006 (%)
  • Table 55: US Vitamins and Minerals value, by brand 2005-2006 (USD m nominal prices)
  • Table 56: US Vitamins and Minerals company share by value, 2005-2006 (%)
  • Table 57: US Vitamins and Minerals value, by company, 2005-2006 (USD m nominal prices)
  • Table 58: US Vitamins and Minerals expenditure per capita, 2001-2006 (USD, nominal prices)
  • Table 59: US Vitamins and Minerals forecast expenditure per capita, 2006-2011 (USD, nominal prices)
  • Table 60: US Plasters & Bandages value, 2001-2006 (USD m, nominal prices)
  • Table 61: US Plasters & Bandages value forecast, 2006-2011 (USD m, nominal prices)
  • Table 62: US Plasters & Bandages brand share, by value, 2005-2006 (%)
  • Table 63: US Plasters & Bandages value, by brand 2005-2006 (USD m nominal prices)
  • Table 64: US Plasters & Bandages company share by value, 2005-2006 (%)
  • Table 65: US Plasters & Bandages value, by company, 2005-2006 (USD m nominal prices)
  • Table 66: US Plasters & Bandages expenditure per capita, 2001-2006 (USD, nominal prices)
  • Table 67: US Plasters & Bandages forecast expenditure per capita, 2006-2011 (USD, nominal prices)
  • Table 68: US Medicated Skin Products value, 2001-2006 (USD m, nominal prices)
  • Table 69: US Medicated Skin Products value forecast, 2006-2011 (USD m, nominal prices)
  • Table 70: US Medicated Skin Products brand share, by value, 2005-2006 (%)
  • Table 71: US Medicated Skin Products value, by brand 2005-2006 (USD m nominal prices)
  • Table 72: US Medicated Skin Products company share by value, 2005-2006 (%)
  • Table 73: US Medicated Skin Products value, by company, 2005-2006 (USD m nominal prices)
  • Table 74: US Medicated Skin Products expenditure per capita, 2001-2006 (USD, nominal prices)
  • Table 75: US Medicated Skin Products forecast expenditure per capita, 2006-2011 (USD, nominal prices)
  • Table 76: US Other OTC Healthcare Products value, 2001-2006 (USD m, nominal prices)
  • Table 77: US Other OTC Healthcare Products value forecast, 2006-2011 (USD m, nominal prices)
  • Table 78: US Other OTC Healthcare Products brand share, by value, 2005-2006 (%)
  • Table 79: US Other OTC Healthcare Products value, by brand 2005-2006 (USD m nominal prices)
  • Table 80: US Other OTC Healthcare Products company share by value, 2005-2006 (%)
  • Table 81: US Other OTC Healthcare Products value, by company, 2005-2006 (USD m nominal prices)
  • Table 82: US Other OTC Healthcare Products expenditure per capita, 2001-2006 (USD, nominal prices)
  • Table 83: US Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (USD nominal prices)
  • Table 84: US Topical OTC Medicines value, 2001-2006 (USD m, nominal prices)
  • Table 85: US Topical OTC Medicines value forecast, 2006-2011 (USD m, nominal prices)
  • Table 86: US Topical OTC Medicines brand share, by value, 2005-2006 (%)
  • Table 87: US Topical OTC Medicines value, by brand 2005-2006 (USD m nominal prices)
  • Table 88: US Topical OTC Medicines company share by value, 2005-2006 (%)
  • Table 89: US Topical OTC Medicines value, by company, 2005-2006 (USD m nominal prices)
  • Table 90: US Topical OTC Medicines expenditure per capita, 2001-2006 (USD, nominal prices)
  • Table 91: US Topical OTC Medicines forecast expenditure per capita, 2006-2011 (USD, nominal prices)
  • Table 92: Global OTC Healthcare market value, 2006
  • Table 93: Global OTC Healthcare market split (value terms (US$ m), 2006) Top 5 countries
  • Table 94: Leading players - Top 5 countries
  • Table 95: US OTC Healthcare new product launches (reports) and SKUs, by company (Top 5 companies), 2006
  • Table 96: US OTC Healthcare new product launches (reports), by flavor and fragrances (Top 10 flavors), 2006
  • Table 97: US OTC Healthcare new product launches (reports), by Ingredients (Top 10 Ingredients), 2006
  • Table 98: US OTC Healthcare new product launches (reports), by Package tags or Claims (Top 10 claims), 2006
  • Table 99: US OTC Healthcare new product launches (reports) - Recent 5 launches
  • Table 100: US Key Facts
  • Table 101: US population, by age group, 2000-2005 (millions)
  • Table 102: US population forecast, by age group, 2005-2010 (millions)
  • Table 103: US population, by gender, 2000-2005 (millions)
  • Table 104: US population forecast, by gender, 2005-2010 (millions)
  • Table 105: US real GDP, 2000-2005 (USD bn, 2005 prices)
  • Table 106: US real GDP forecast, 2005-2010 (USD bn, 2005 prices)
  • Table 107: US nominal GDP, 2000-2005 (USD bn, nominal prices)
  • Table 108: US real GDP, 2000-2005 (US$ bn, 2005 prices)
  • Table 109: US real GDP forecast, 2005-2010 (US$ bn, 2005 prices)
  • Table 110: US consumer price index, 2000-2005 (2000=100)
  • Table 111: US consumer price index, 2005-2010 (2000=100)
  • Table 112: US exchange rate, 2000-2005